According to Reuters, the IntercontinentalExchange (ICE) sweetened its bid for the CBOT (BOT).
The Wall Street Journal writes that the largest shareholder in Ceridian (CEN) will oppose its sale to Thomas Lee Partners for $5.3 billion.
The Wall Street Journal reports that Airbus has only 13 firm orders for its A350 compared to over 600 for the rival Boeing (BA) 787.
The Wall Street Journal also writes that a federal court refused to throw out a suit against Boston Scientific (BSX) over alledgedly faulty defibrillators.
The WSJ also reports that shareholders have sued GlaxoSmithKline (GSK) saying that the company mislead the market about the safety of its drug Avandia.
According to The New York Times, news management at The Wall Street Journal will be shaken up by its new editor.
The New York Times writes that ConAgra (CAG) is overhauling some of its major brands in a bid to increase revenue.
FT reports that Barclays (BCS) is preparing to improve its bid for ABN Amro (ABN).
Barron’s writes that Comcast (CMCSA) is now one of the cheapest stocks in the S&P 500 according to certain measurements.
Douglas A. McIntyre